Detailseite
Projekt Druckansicht

Molekulare Charakterisierung der Skap2-vermittelten Integrinaktivierung, Leukozytenaktivierung und -rekrutierung

Fachliche Zuordnung Anästhesiologie
Förderung Förderung von 2016 bis 2022
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 287891957
 
Erstellungsjahr 2022

Zusammenfassung der Projektergebnisse

Integrin activation is required for neutrophil functions. Impaired integrin activation on neutrophils is the hallmark of leukocyte adhesion deficiency (LAD) syndrome in humans, characterized by impaired leukocyte recruitment and recurrent infections. In mice, loss of Src kinase-associated phosphoprotein 2 (Skap2) is sufficient to cause a LAD-like phenotype in mice. In this study we demonstrate that Skap2 plays a pivotal role during integrin activation and neutrophil recruitment. Reduced leukocyte recruitment in a model of sterile liver injury, and also acute kidney injury, improved outcome and ameliorated disease severity in Skap2- deficient mice compared to WT mice. We analyzed in detail the function of Skap2 and provide evidence, that Skap2-function is dependent on the direct interaction with Wiskott-Aldrich syndrome protein (WASp) via it SH3 domain. Furthermore, Skap2 regulates integrin-mediated outside-in signaling events and neutrophil effector functions, such as release of reactive oxygen species, phagocytosis, or the release of neutrophil extracellular traps. Due to this central role during inflammation, it might be a promising target for potential therapeutic interventions during sterile inflammatory disorders.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung